» Articles » PMID: 35626349

Hyperspectral Imaging for Assessment of Initial Graft Function in Human Kidney Transplantation

Overview
Specialty Radiology
Date 2022 May 28
PMID 35626349
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of our study was to evaluate hyperspectral imaging (HSI) as a rapid, non-ionizing technique for the assessment of organ quality and the prediction of delayed graft function (DGF) in kidney transplantation after static cold storage (SCS, n = 20), as well as hypothermic machine perfusion (HMP, n = 18). HSI assessment of the kidney parenchyma was performed during organ preservation and at 10 and 30 min after reperfusion using the TIVITA Tissue System (Diaspective Vision GmbH, Am Salzhaff, Germany), calculating oxygen saturation (StO), near-infrared perfusion index (NIR), tissue haemoglobin index (THI), and tissue water index (TWI). Recipient and donor characteristics were comparable between organ preservation groups. Cold ischemic time was significantly longer in the HMP group (14.1 h [3.6-23.1] vs. 8.7h [2.2-17.0], = 0.002). The overall presence of DGF was comparable between groups (HMP group n = 10 (55.6%), SCS group n = 10 (50.0%)). Prediction of DGF was possible in SCS and HMP kidneys; StO at 10 (50.00 [17.75-76.25] vs. 63.17 [27.00-77.75]%, = 0.0467) and 30 min (57.63 [18.25-78.25] vs. 65.38 [21.25-83.33]%, = 0.0323) after reperfusion, as well as NIR at 10 (41.75 [1.0-58.00] vs. 48.63 [12.25-69.50], = 0.0137) and 30 min (49.63 [8.50-66.75] vs. 55.80 [14.75-73.25], = 0.0261) after reperfusion were significantly lower in DGF kidneys, independent of the organ preservation method. In conclusion, HSI is a reliable method for intraoperative assessment of renal microperfusion, applicable after organ preservation through SCS and HMP, and predicts the development of DGF.

Citing Articles

Hyperspectral imaging in living and deceased donor kidney transplantation.

Wrigge R, Sucher R, Haak F, Meyer H, Unruh J, Hau H BMC Med Imaging. 2025; 25(1):34.

PMID: 39891083 PMC: 11786449. DOI: 10.1186/s12880-025-01576-6.


Hyperspectral imaging of human liver allografts for prediction of initial graft function.

Vogt F, Wagner T, Katou S, Kneifel F, Vogel T, Morgul H Langenbecks Arch Surg. 2024; 409(1):306.

PMID: 39400566 PMC: 11473603. DOI: 10.1007/s00423-024-03497-4.


Imaged guided surgery during arteriovenous malformation of gastrointestinal stromal tumor using hyperspectral and indocyanine green visualization techniques: A case report.

Wagner T, Mustafov O, Hummels M, Grabenkamp A, Thomas M, Schiffmann L World J Clin Cases. 2023; 11(23):5530-5537.

PMID: 37637700 PMC: 10450370. DOI: 10.12998/wjcc.v11.i23.5530.


Hyperspectral imaging as a new diagnostic tool for cervical intraepithelial neoplasia.

Schimunek L, Schopp K, Wagner M, Brucker S, Andress J, Weiss M Arch Gynecol Obstet. 2023; 308(5):1525-1530.

PMID: 37574506 PMC: 10520109. DOI: 10.1007/s00404-023-07171-w.

References
1.
Mueller T, Solez K, Mas V . Assessment of kidney organ quality and prediction of outcome at time of transplantation. Semin Immunopathol. 2011; 33(2):185-99. DOI: 10.1007/s00281-011-0248-x. View

2.
Yarlagadda S, Coca S, Formica Jr R, Poggio E, Parikh C . Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant. 2008; 24(3):1039-47. DOI: 10.1093/ndt/gfn667. View

3.
Dahmen M, Becker F, Pavenstadt H, Suwelack B, Schutte-Nutgen K, Reuter S . Validation of the Kidney Donor Profile Index (KDPI) to assess a deceased donor's kidneys' outcome in a European cohort. Sci Rep. 2019; 9(1):11234. PMC: 6677881. DOI: 10.1038/s41598-019-47772-7. View

4.
Kohler H, Jansen-Winkeln B, Chalopin C, Gockel I . Hyperspectral imaging as a new optical method for the measurement of gastric conduit perfusion. Dis Esophagus. 2019; 32(10):1. DOI: 10.1093/dote/doz046. View

5.
Halloran P, Hunsicker L . Delayed graft function: state of the art, November 10-11, 2000. Summit meeting, Scottsdale, Arizona, USA. Am J Transplant. 2002; 1(2):115-20. View